90. Retinitis pigmentosa
103 clinical trials,   158 drugs   (DrugBank: 42 drugs),   52 drug target genes,   107 drug target pathways

Searched query = "Retinitis pigmentosa", "Rod dystrophy", "Rod-Cone Dystrophy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000006820
2009/02/0102/12/2011Neuroprotective efficacy of topical unoprostone isopropyl or nipradilol in patients with retinitis pigmentosa retinitis pigmentosa0.12% topical unoprostone isopropyl twice daily
0.25% topical nipradilol twice daily
Kyushu university hospitalNULLComplete: follow-up completeNot applicableNot applicableMale and Female50Not selectedJapan
2JPRN-JapicCTI-090748
01/10/200820/04/2009Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosaPhase II Study of 0.15% UF-021 in patients with retinitis pigmentosa retinitis pigmentosaIntervention name : UF-021 (isopropyl unoprostone)
Dosage And administration of the intervention : Eye drop
R-Tech Ueno, LtdNULL2065BOTH105Phase 2NULL
3JPRN-JapicCTI-132079
Phase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration PeriodPhase 3 Clinical Study of UF-021 for Retinitis Pigmentosa - Evaluation for a Comparative Double Masked Placebo Controlled Study Period and a Continuous Administration Period Retinitis PigmentosaIntervention name : UF-021(isopropyl unoprostone)
Dosage And administration of the intervention : Eye drop
Control intervention name : null
R-Tech Ueno, LtdNULL2070BOTHPhase 3NULL